A small error in reconstitution math can lead to doses that are double or half of what was intended
BPC-157 has been thoroughly researched for its therapeutic potential in a variety of conditions, including musculoskeletal injuries, digestive disorders, neurological conditions, autoimmune diseases, and skin and soft tissue injuries
The 10 mg dose was not studied as a specific tier in Phase 2
Doctors are expecting an onslaught of new patients: As Axios reported in June, clinics are worried they may be overwhelmed by the increased demand that follows the Bridge programs launch
Canyelles M, Tondo M, Ced L, Farrs M, Escol-Gil JC, Blanco-Vaca F
Parkinsons disease psychosis: presentation, diagnosis and management